BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8759268)

  • 1. Sulphapyridine--a new agent for the treatment of ocular cicatricial pemphigoid.
    Elder MJ; Leonard J; Dart JK
    Br J Ophthalmol; 1996 Jun; 80(6):549-52. PubMed ID: 8759268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid.
    Elder MJ; Lightman S; Dart JK
    Br J Ophthalmol; 1995 Mar; 79(3):264-6. PubMed ID: 7703207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of disease in ocular cicatricial pemphigoid.
    Elder MJ; Bernauer W; Leonard J; Dart JK
    Br J Ophthalmol; 1996 Apr; 80(4):292-6. PubMed ID: 8703876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.
    Miserocchi E; Baltatzis S; Roque MR; Ahmed AR; Foster CS
    Ophthalmology; 2002 Jan; 109(1):111-8. PubMed ID: 11772589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ocular Cicatricial Pemphigoid - a Retrospective Study].
    Szabó E; Palos M; Skalická P
    Cesk Slov Oftalmol; 2016 Feb; 72(1):283-92. PubMed ID: 27041284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate therapy for ocular cicatricial pemphigoid.
    McCluskey P; Chang JH; Singh R; Wakefield D
    Ophthalmology; 2004 Apr; 111(4):796-801. PubMed ID: 15051215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive therapy for ocular mucous membrane pemphigoid strategies and outcomes.
    Saw VP; Dart JK; Rauz S; Ramsay A; Bunce C; Xing W; Maddison PG; Phillips M
    Ophthalmology; 2008 Feb; 115(2):253-261.e1. PubMed ID: 17655931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of ocular disease in mucous membrane pemphigoid.
    Brunner M; Lacoste KJ; Bernauer W
    Klin Monbl Augenheilkd; 2014 Apr; 231(4):331-4. PubMed ID: 24771161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
    Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
    Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications].
    Messmer EM; Hintschich CR; Partscht K; Messer G; Kampik A
    Ophthalmologe; 2000 Feb; 97(2):113-20. PubMed ID: 10734737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular cicatricial pemphigoid: manifestations and management.
    Chang JH; McCluskey PJ
    Curr Allergy Asthma Rep; 2005 Jul; 5(4):333-8. PubMed ID: 15967079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of ocular cicatricial pemphigoid with tacrolimus (FK 506).
    Letko E; Ahmed AR; Foster CS
    Graefes Arch Clin Exp Ophthalmol; 2001 Jul; 239(6):441-4. PubMed ID: 11561793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior lamellar repositioning and grey line split for upper lid entropion in ocular cicatricial pemphigoid.
    Elder MJ; Collin R
    Eye (Lond); 1996; 10 ( Pt 4)():439-42. PubMed ID: 8944093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Approach to Ocular Cicatricial Pemphigoid.
    Çiftçi MD; Korkmaz İ; Palamar M; Yaman B; Eğrilmez S; Yağcı A; Akalın T; Barut Selver Ö
    Turk J Ophthalmol; 2023 Apr; 53(2):79-84. PubMed ID: 37089009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic chemotherapy for ocular cicatricial pemphigoid.
    Tauber J; Sainz de la Maza M; Foster CS
    Cornea; 1991 May; 10(3):185-95. PubMed ID: 2055022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of ocular cicatricial pemphigoid with sulfasalazine.
    Doan S; Lerouic JF; Robin H; Prost C; Savoldelli M; Hoang-Xuan T
    Ophthalmology; 2001 Sep; 108(9):1565-8. PubMed ID: 11535451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapsone therapy for the acute inflammatory phase of ocular pemphigoid.
    Fern AI; Jay JL; Young H; MacKie R
    Br J Ophthalmol; 1992 Jun; 76(6):332-5. PubMed ID: 1622942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study.
    Foster CS; Ahmed AR
    Ophthalmology; 1999 Nov; 106(11):2136-43. PubMed ID: 10571350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long-term follow-up.
    Sami N; Letko E; Androudi S; Daoud Y; Foster CS; Ahmed AR
    Ophthalmology; 2004 Jul; 111(7):1380-2. PubMed ID: 15234140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and adverse reactions of methotrexate in the treatment of ocular cicatricial pemphigoid: A case series study.
    Shi Y; Xie C; He Y; Liu H; Zhu B; Zhu J
    Medicine (Baltimore); 2018 Sep; 97(38):e12338. PubMed ID: 30235689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.